Ritgen Jochen, Roxin Julia, Kolsch Marit, Bergsch Arne, Degenhardt Jan
Center for Prenatal Medicine and Genetics, Praenatal Plus, Cologne, DEU.
Medical Department, Justus-Liebig-University, Giessen, DEU.
Cureus. 2024 Jun 13;16(6):e62309. doi: 10.7759/cureus.62309. eCollection 2024 Jun.
Introduction Pre-eclampsia (PE) is a common diagnosis in pregnancy and affects pregnancies worldwide. Early-onset PE often leads to severe maternal and fetal complications. Prophylactic use of aspirin (150 mg/day) before the 16th week of pregnancy can reduce the risk of PE. This study aimed to investigate the effects of maternal factors on the development of uteroplacental perfusion and fetal biometry from the first to the second trimester in a risk group receiving aspirin prophylaxis compared to a control group without Aspirin. Methods This case-control study included 448 women at high risk for PE (risk group, RG) receiving aspirin prophylaxis and 468 women at low PE risk without aspirin intake (control group, CG). Parameters recorded and considered in the first (T1) and second (T2) trimesters included uterine artery pulsatility multiple of the median (UtAPI MoM), notching at T1 and T2 and fetal biometry parameters at T2. Maternal factors were also captured, and their respective effects were examined. Results UtAPI MoM at T1 and T2 showed a significant positive correlation (r = 0.39, p < 0.001), with UtAPI MoM at T2 significantly higher for notching "yes" at T1. Pre-existing arterial hypertension and UtAPI development demonstrated a significant association (p = 0.006). Women without this risk factor showed a significantly (p < 0.001) greater decline in UtAPI development. The likelihood of notching "yes" at T2 (p < 0.001; OR: 5.80) was increased with higher UtAPI MoM at T1. The mean values (T1 and T2) of UtAPI MoM were significantly higher in the risk group than in the control group. Patients in the risk group exhibited notching at T2 (p < 0.001; OR: 5.64) more often compared to the control group. The 95% CI of the estimated fetal weight for notching "yes" at T1 was below the 50th percentile. Gestational age and head circumference/abdomen circumference (HC/AC) ratio showed a significant negative correlation (p < 0.001; b = -0.01). The control group showed significantly higher estimated fetal weights than the risk group. The HC/AC ratio in the risk group was above the HC/AC ratio in the control group but without proving significance. Conclusions Persistent notching and elevated UtAPI MoM levels in the second trimester may be risk factors for early-onset PE. Women with pre-existing arterial hypertension, notching and elevated UtAPI MoM values in the first and second trimesters require special monitoring during the course of pregnancy.
引言 子痫前期(PE)是孕期常见的诊断疾病,影响着全球各地的妊娠。早发型PE常导致严重的母婴并发症。在妊娠16周前预防性使用阿司匹林(150毫克/天)可降低PE风险。本研究旨在调查与未使用阿司匹林的对照组相比,在接受阿司匹林预防的风险组中,孕早期至孕中期母体因素对子宫胎盘灌注发育和胎儿生物测量的影响。
方法 本病例对照研究纳入了448名接受阿司匹林预防的PE高危女性(风险组,RG)和468名未摄入阿司匹林的低PE风险女性(对照组,CG)。在孕早期(T1)和孕中期(T2)记录并考虑的参数包括子宫动脉搏动指数中位数倍数(UtAPI MoM)、T1和T2时的切迹以及T2时的胎儿生物测量参数。还记录了母体因素,并检查了它们各自的影响。
结果 T1和T2时的UtAPI MoM呈显著正相关(r = 0.39,p < 0.001),T1时切迹为“是”的T2时UtAPI MoM显著更高。既往动脉高血压与UtAPI发育呈显著关联(p = 0.006)。无此风险因素的女性UtAPI发育下降幅度显著更大(p < 0.001)。T1时UtAPI MoM越高,T2时切迹为“是”的可能性越大(p < 0.001;OR:5.80)。风险组中UtAPI MoM的平均值(T1和T2)显著高于对照组。与对照组相比,风险组患者T2时出现切迹的情况更频繁(p < 0.001;OR:5.64)。T1时切迹为“是”的估计胎儿体重的95%置信区间低于第50百分位数。孕周与头围/腹围(HC/AC)比值呈显著负相关(p < 0.001;b = -0.01)。对照组的估计胎儿体重显著高于风险组。风险组的HC/AC比值高于对照组,但未显示出显著性。
结论 孕中期持续的切迹和升高的UtAPI MoM水平可能是早发型PE的危险因素。在妊娠期间,患有既往动脉高血压、孕早期和孕中期有切迹以及UtAPI MoM值升高的女性需要特别监测。